Dexlansoprazole Capsule, Delayed Release
Product Images NDC 46708-824

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dexlansoprazole (NDC 46708-824). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dexlansoprazole-30-mg-capsule (Dexlansoprazole 30 mg Capsule)

Dexlansoprazole-30-mg-capsule (Dexlansoprazole 30 mg Capsule)
Label of Dexlansoprazole Delayed-Release Capsules 30 mg by Alembic Pharmaceuticals Limited. The label shows NDC 46708-823-30, packaging with 30 capsules, and storage instructions at controlled room temperature. It includes a barcode, manufacturer details in Gujarat, India, and a note for pharmacists to dispense the medication guide.*
FDA Label Image

Dexlansoprazole-60-mg-capsule (Dexlansoprazole 60 mg Capsule)

Dexlansoprazole-60-mg-capsule (Dexlansoprazole 60 mg Capsule)
Dexlansoprazole Delayed-Release Capsules 60 mg bottle label indicating a package of 30 capsules. Manufactured by Alembic Pharmaceuticals Limited, the label includes storage instructions, a barcode, and pharmacy dispensing guidance. The product is described as containing 60 mg of dexlansoprazole as enteric coated pellets with child-resistant packaging.*
FDA Label Image

Dexlansoprazole-fig1.jpg (Dexlansoprazole Fig1)

Dexlansoprazole-fig1.jpg (Dexlansoprazole Fig1)
A pharmacokinetic profile chart showing plasma concentration (ng/mL) of Dexlansoprazole over time (hours) after oral administration. The graph compares two dosage strengths, 30 mg and 60 mg, with plasma concentration curves peaking earlier and higher for the 60 mg dose.*
FDA Label Image

Dexlansoprazole-str.jpg (Dexlansoprazole Str)

Dexlansoprazole-str.jpg (Dexlansoprazole Str)
Chemical structure of dexlansoprazole, showing its molecular arrangement including a sulfoxide group, pyridine ring with a methyl substituent, and trifluoroethoxy substituent.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.